Skip to content

Novacyt Shares Surge 10.8% on Upbeat H1 Results

Shares of Novacyt SA (LON: NCYT) today surged 10.8% after the company reported a significant jump in H1 2020 profits driven by rising demand for COVID-19 tests.

The company, which produces clinical diagnostics tools made a profit of €40.2 million ($47.5 million)  before taxes during the six month period as compared to the 2.0 million loss reported during a similar period last year.

The company’s sales rose more than ten times to reach €72.4 as compared to last year.

High demand for Novacyt’s PCR COVID-19 test was the main driver behind the company’s positive results.

The firm repaid all its outstanding debts and made a major investment in its inventory, yet it was left with €19.7 million in cash flow as of June 30.

The company also revealed that it had adopted a new strategy to maintain its current growth trajectory by extending its portfolio to include respiratory and transplant clinical diagnostics.

The firm said that the orders made for its COVID-19 product portfolio so far indicate that H2 2020 results could exceed H1 results.

Novacyt share price

Tradingview chart of Novacyt share price 17092020

Novacyt shares surged 10.8% today to trade at 410p having closed Wednesday’s session trading at 370p.

People who read this also read:

Simon Mugo
Simon Mugo
Contributor

Simon has over six years of professional trading experience across FX, commodities and equities. He has a strong passion for financial markets and is particularly focused on price action trading

Stay ahead of the markets

Sign up to our free Morning Markets email, every weekday before the open.